Unlimited, Affordable Amniotic Cells for Regenerative Medicine
AmnioCam aims to provide a reliable, scalable supply of high-quality amniotic cells, revolutionising wound care, cosmetics, and research applications.
About
Who Are We?
AmnioCam is working towards an affordable, unlimited supply of high-quality amnion cells for clinical and research applications. From the Babraham Institute, we are a research team looking to advance regenerative medicine by ensuring consistent access to amnion cells for wound healing and research—making cutting-edge therapies more accessible.
Problem
The Challenge: Limited Supply and High Costs
Amniotic membranes are highly valued in tissue engineering and cell therapies for their anti-inflammatory and immunomodulatory properties, ability to promote tissue repair, and safety from tumorigenicity. However, current amnion-based products face challenges like limited supply, high cost, and variability, restricting broader use. Developing scalable, consistent sources of human amniotic epithelial cells is essential to advance their clinical and research applications.
Our SOLUTION
Scalable, Cost-Effective Amniotic Cells
Dr. Peter Rugg-Gunn and Dr. Maria Rostovskaya from the Babraham Institute developed a novel method to produce amniotic epithelial cells from human pluripotent stem cells (hPSCs). This innovation provides a reliable, scalable, and cost-effective alternative to donor placenta-derived cells, which face supply and variability challenges. The hPSC-derived cells mimic the bioactive properties of natural amnion, offering significant potential in tissue repair and wound healing. This addresses an unmet need for consistent, standardized amnion cells in clinical and research applications.
Furthermore, the research team developed a method to produce hPSC-derived amniotic cells with bioactive properties matching placental cells. These cells express key amnion markers, ensure high purity, and can be cryopreserved or lyophilized for long-term storage while maintaining bioactivity. Their scalable, production process is suitable for clinical applications. Tests show these cells promote fibroblast proliferation and migration, essential for wound healing, and effectively aid repair in human skin models, highlighting their therapeutic potential.
kEY BENEFITS
Why Choose AmnioCam?
Unlimited Supply
We’ve eliminated reliance on tissue donations, providing a scalable solution that meets demand across multiple fields.
Affordable Production
Our innovative process drastically reduces costs, making advanced cell therapies accessible and cost-effective.
Consistent Quality
With standardised production, every batch meets stringent quality standards, streamlining regulatory approval and ensuring reliable performance.
Therapeutics
Supporting wound healing and treatment of rare diseases with an accessible supply of amniotic cells.
Cosmetics
Powering next-generation skincare and anti-aging products with cell-based technology.
Veterinary
Providing regenerative treatments for pets and large animals, ideal for wound care and musculoskeletal issues.
Research
- Offering a consistent cell supply for stem cell studies, differentiation research, and regenerative medicine innovations.
Help Shape the Future of Regenerative Medicine
We want to hear from you! Whether you’re in therapeutics, cosmetics, veterinary, or research, your input helps us better understand the needs and challenges in regenerative medicine. Take a quick survey and contribute to the future of healing.
Stay Connected
Get In Touch
Are you interested in learning more about AmnioCam’s potential or collaborating in the early stages of our journey? We’re actively researching and refining our approach to making amnion cells more accessible and affordable. Whether you’re in regenerative medicine, cosmetics, veterinary care, or research, we’d love to hear your insights and answer any questions.